Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 46 Triple Negative Breast Neoplasms 4 Carcinoma, Intraductal, Noninfiltrating 3 Recurrence 2 Unilateral Breast Neoplasms 1 Pain 1 Neoplasms 1 Lymphedema 1 Li-Fraumeni Syndrome 1 Inflammation 1 Hamartoma Syndrome, Multiple 1 Cystic Fibrosis 1 Carcinoma, Ductal, Breast 1 Breast Carcinoma In Situ 1 Breast Cancer Invasive 1 Breast Cancer Female 1 Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Sirolimus 3 Everolimus 2 dactolisib 1 Physical Examination 1 Mastectomy, Subcutaneous 1 Mastectomy 1 Fluorodeoxyglucose F18 1 Colonoscopy 1 8-(6-methoxypyridin-3-yl)-3-methyl-1-(4-piperazin-1-yl-3-trifluoromethylphenyl)-1,3-dihydroimidazo(4,5-c)quinolin-2-one 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hamartoma Syndrome, Multiple × Mastectomy × Clear all

NCT06888388 2025-12-08

NSM

Sir Mortimer B. Davis - Jewish General Hospital

Hamartoma Syndrome, Multiple, Li-Fraumeni Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡